The global clinical microbiology market was valued at USD 8.4 billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024. Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceutical, and clinical applications for investigation and diagnosis of various infectious diseases.
The market is rapidly growing due to the increasing adoption of automated and advanced technologies for laboratory instruments and analyzers in developed countries. Growing geriatric population and thereby rising prevalence of infectious diseases is one of the major factors boosting the adoption of clinical microbiology in healthcare sector for disease diagnosis and monitoring. In addition, industry is gaining high momentum with launch of innovative products such as MALDI Biotyper, GeneXpert and Myla IT performance management solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R, commercialization of clinical microbiology devices is expected to increase significantly over the next few years.
In North America, the government authorities and private companies have significantly contributed toward technology development, research funding, and commercialization of clinical microbiology associated devices.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
Global Clinical Microbiology Market, 2014 - 2024 (USD Million)
·
Rapid adoption of technology and automation of
laboratory work flow, laboratory instrument segement is expected to be the
fastest growing segment with CAGR of 8.6% over the forecast period.
·
Reagents is the largest segment with market
share of 34.7% in 2015. Repeat purchase of reagents contribute to its growth
thus it is the largest growing segment in market.
·
In 2015, North America dominated the global
market with largest revenue share of 41.0%. The continuous research on
infectious disease treatment, and subsequent grant from government healthcare
agencies are contributing to the development of a strong ecosystem for the
expansion of clinical microbiology in the region.
·
Asia Pacific is expected to emerge as the
fastest growing region during the forecast period. The growing geriatric
population in India, China and Japan leading to increase in the prevalence of
re-emerging infectious diseases such as tuberculosis, cholera and typhoid in
this region are expected to promote the utilization of clinical application of
microbiology in healthcare.
·
The clinical microbiology Industry is presently
dominated by a few key participants such as bioMerieux S.A., Cepheid Inc.,
Danaher Corporation and Bruker Corporation. Some of the prominent players
operating in the market include but are not limited to Becton Dickinson &
Company, Hologic Inc., Roche Diagnostics and Alere Inc. Introduction of
automated systems and innovative designs, is expected to intensify the competition
by changing the market dynamics over the forecast period.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the clinical microbiology market by product, application, disease and region:
Product Outlook (Market revenue in USD Million, 2014 - 2024)
·
Laboratory Instruments
·
Incubators
·
Gram Stainers
·
Bacterial Colony Counters
·
Autoclave Sterilizers
·
Microbial Air Samplers
·
Petri Dish Fillers
·
Culture Systems
·
Microbiology Analyzers
·
Molecular Diagnostic Instruments
·
Microscopes
·
Mass Spectrometers
·
Reagents
Application Outlook (Market Revenue in USD Million, 2014 - 2024)
·
Respiratory Infections
·
Bloodstream Infections
·
Gastrointestinal Infections
·
Sexually Transmitted Infections
·
Urinary tract Infections
·
Periodontal Infections
Regional Outlook (Market Revenue in USD Million, 2014 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/global-clinical-microbiology-market
No comments:
Post a Comment